Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Dischinger

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 19, 2021
Plasma Steroid Profiling in Patients With Adrenal IncidentalomaKristina Berke, Georgiana Constantinescu, Jimmy Masjkur, et al.
Metabolism: Clinical and Experimental|November 7, 2022
Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional studyUlrich Dischinger, Laura Kötzner, Petia Kovatcheva-Datchary, et al.
Frontiers in Endocrinology|December 27, 2024
Mild autonomous cortisol secretion leads to reduced volumetric BMD at lumbar spine in patients with primary aldosteronismNabeel Mansour, Denise Bruedgam, Daniel Heinrich, et al.
The Journal of Applied Laboratory Medicine|March 27, 2024
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient StudySybille Fuld, Georgiana Constantinescu, Christina Pamporaki, et al.
Cancers|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood NeutrophilsSimone Wendlinger, Jonas Wohlfarth, Claudia Siedel, et al.
The Journal of Physiology|April 4, 2025
Ketogenic diet and ketone salts differentially improve cardiometabolic complications in an HFpEF rat modelAlexandre Gonçalves, Inês N Alves, Cláudia Mendes, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 2, 2025
Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paragangliomaAlessa Fischer, Hanna Remde, Christina Pamporaki, et al.
Orphanet Journal of Rare Diseases|February 5, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an updateLucas Bouys, Anna Vaczlavik, Isadora P Cavalcante, et al.
European Journal of Endocrinology|November 10, 2023
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort studyAlessa Fischer, Simon Kloos, Hanna Remde, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|October 19, 2021
Plasma Steroid Profiling in Patients With Adrenal IncidentalomaKristina Berke, Georgiana Constantinescu, Jimmy Masjkur, et al.
Metabolism: Clinical and Experimental|November 7, 2022
Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional studyUlrich Dischinger, Laura Kötzner, Petia Kovatcheva-Datchary, et al.
Frontiers in Endocrinology|December 27, 2024
Mild autonomous cortisol secretion leads to reduced volumetric BMD at lumbar spine in patients with primary aldosteronismNabeel Mansour, Denise Bruedgam, Daniel Heinrich, et al.
The Journal of Applied Laboratory Medicine|March 27, 2024
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient StudySybille Fuld, Georgiana Constantinescu, Christina Pamporaki, et al.
Cancers|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood NeutrophilsSimone Wendlinger, Jonas Wohlfarth, Claudia Siedel, et al.
The Journal of Physiology|April 4, 2025
Ketogenic diet and ketone salts differentially improve cardiometabolic complications in an HFpEF rat modelAlexandre Gonçalves, Inês N Alves, Cláudia Mendes, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 2, 2025
Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paragangliomaAlessa Fischer, Hanna Remde, Christina Pamporaki, et al.
Orphanet Journal of Rare Diseases|February 5, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an updateLucas Bouys, Anna Vaczlavik, Isadora P Cavalcante, et al.
European Journal of Endocrinology|November 10, 2023
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort studyAlessa Fischer, Simon Kloos, Hanna Remde, et al.
Pageof 6